Cover Image
Market Research Report

Liquid Biopsy Market, by Sample Type, By Technology (Multi-gene-parallel Analysis, and Single Gene Analysis ), By Biomaker, By Application, By Technology, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026

Published by AnalystView Market Insights Product code 941384
Published Content info 198 Pages
Delivery time: 2-3 business days
Price
Back to Top
Liquid Biopsy Market, by Sample Type, By Technology (Multi-gene-parallel Analysis, and Single Gene Analysis ), By Biomaker, By Application, By Technology, and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026
Published: June 1, 2020 Content info: 198 Pages
Description

REPORT HIGHLIGHT

Liquid biopsy Market was valued at USD 49.72 million by 2019, growing with 14.6% CAGR during the forecast period, 2020-2026

Market Dynamics

Liquid biopsy is a non-invasive and easy method used to diagnose onset of cancer. Liquid biopsy is also called as fluid phase biopsy or fluid biopsy. With liquid biopsy tumors and mutations can be easily tracked over a period of time. For cancer treatment, safety and efficiency is improved by the use of these tests because of their ability to predict treatment outcome, execute apt therapeutic targets, and characterize new lesions.

The growing number of patients being diagnosed with several types of cancer and the advantages of liquid biopsy such as metastatic relapse and minimally invasive are the major factors driving the growth of global liquid biopsy market. According to World Health Organization (WHO), cancer is the second leading cause of death all over the world. Around 9.6 million deaths in 2018 were due to various types of cancer. Moreover, minimally invasive therapies are highly preferred by patients and a surge in disposable income is also witnessed among cancer patients, which is anticipated to propel the market growth during the forecast period. In addition, an increase in healthcare expenditure in the emerging economies such as China and India and growing use of biopsy tests are likely to create lucrative opportunities in the global industry. However, unclear regulation & reimbursement scenario and availability of alternatives to liquid biopsies are predicted to restrict the market growth in the coming future.

Sample Type Takeaway

Blood sample-based is anticipated to grow at a significant rate during the forecast period owing to numerous methods for purification and preexisting applications. Microvesicles, exosomes, circulating tumor cells, and cell-free DNA can be detected in blood samples. In the saliva-based sample type, the next generation sequencing technology is used for detecting multiple mutations in multiple genes. As per certain studies plasma and saliva measurements are corelated, which potentially presents that detection of oncogenic gene mutations.

Biomarker Takeaway

CTC biomarkers segment is estimated to hold the largest market share in the forecast period owing to accurate tracking results and high awareness levels of cancerous cells in the human body. The number of circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) based liquid biopsy tests that are commercialized are 8-10. The CTC tests are applicable through biochemical marker analysis for classification of tumor cells through. CTC detection, isolation, and molecular characterization systems find tentative application in pancreatic, prostate, colon, breast, head, skin, neck, and lung cancer.

TECHNOLOGY TAKEAWAY

The multi-gene-parallel analysis (NGS) segment is expected to subjugate the worldwide market owing to its capability to denote diagnosis of multiple diseases at one time. Clinical pharmacogenomics tests are taken away by multigene tests from conventional sequencing of single genes, which is marked as a noteworthy step towards detailed analysis of cancer genome. This technology helps oncologists in guiding patients to the targeted therapy by detecting the genetic aberrations. On the other hand, the single gene analysis-based or PCR-based sequencing is employed for analyzing mutations in particular genes with the help of NGS multiplex testing.

Application Takeaway

The therapy selection for metastatic breast cancer segment is anticipated to witness a considerable growth in the estimated period owing to growing prevalence of metastatic caner all across the globe. It is estimated that liquid biopsy will find application in the molecular monitoring diagnostic, which can be investigated using various biofluids such as saliva, urine, CSF, and blood for patient screening during the forecast period.

REGIONAL TAKEAWAY

Presently, the North America region dominated the global liquid biopsy market in 2018 owing to increasing incidence of cancer and growing need for screening in this region. Europe is estimated to be the second-largest market due to recent regulatory CE approvals for commercial use of liquid biopsy tests.

Key Vendors Takeaway

The major players functioning in the global market are applying several strategies such as mergers & acquisitions and product launches to increase their market share. Some of the prominent players include Guardant Health, Biocept, Personal Genome Diagnostics, Adaptive Biotechnologies, NeoGenomics Laboratories, Cynvenio, Qiagen, RainDance Technologies, and Trovagene.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2015 to 2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2026

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

Scope of the Report

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIQUID BIOPSY MARKET KEY PLAYERS

NeoGenomics Laboratories

Guardant Health

Biocept

Cynvenio

Qiagen

RainDance Technologies

Adaptive Biotechnologies

Personal Genome Diagnostics

Trovagene

GLOBAL LIQUID BIOPSY MARKET, BY SAMPLE TYPE

Urine Sample-based

Blood Sample-based

Other Biofluids

GLOBAL LIQUID BIOPSY MARKET, BY TECHNOLOGY

Multi-gene-parallel Analysis (NGS)

Single Gene Analysis (PCR Microarrays)

GLOBAL LIQUID BIOPSY MARKET, BY BIOMARKER

Circulating Tumor DNA (ctDNA)

Circulating Tumor Cells (CTC)

Exosomes

GLOBAL LIQUID BIOPSY MARKET, BY APPLICATION

Molecular Health Monitoring

Therapy Selection for Metastatic Breast Cancer (MBS)

Therapy Selection for Other Metastatic Cancer

GLOBAL LIQUID BIOPSY MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

Table of Contents

TABLE OF CONTENT

1. LIQUID BIOPSY MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Sample Type
    • 2.1.2. Market Snippet by Technology
    • 2.1.3. Market Snippet by Biomaker
    • 2.1.4. Market Snippet by Application
    • 2.1.5. Market Snippet by Region
  • 2.2. Competitive Insights

3. LIQUID BIOPSY KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. LIQUID BIOPSY INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis
  • 4.5. COVID-19 Impact Analysis
    • 4.5.1. Pre-COVID-19 Impact Analysis
    • 4.5.2. Post-COVID-19 Impact Analysis

5. LIQUID BIOPSY MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. LIQUID BIOPSY MARKET - BY SAMPLE TYPE

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Sample Type, 2019 & 2026 (%)
  • 6.2. Urine Sample-based
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Blood Sample-based
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.4. Other Biofluids
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. LIQUID BIOPSY MARKET - BY TECHNOLOGY

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2019 & 2026 (%)
  • 7.2. Multi-gene-parallel Analysis (NGS)
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Single Gene Analysis (PCR Microarrays)
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. LIQUID BIOPSY MARKET - BY BIOMAKER

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Biomaker, 2019 & 2026 (%)
  • 8.2. Circulating Tumor DNA (ctDNA)
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.3. Circulating Tumor Cells (CTC)
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 8.4. Exosomes
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. LIQUID BIOPSY MARKET - BY APPLICATION

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)
  • 9.2. Molecular Health Monitoring
    • 9.2.1. Overview
    • 9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.3. Therapy Selection for Metastatic Breast Cancer (MBS)
    • 9.3.1. Overview
    • 9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 9.4. Therapy Selection for Other Metastatic Cancer
    • 9.4.1. Overview
    • 9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. LIQUID BIOPSY MARKET- BY GEOGRAPHY

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Sample Type, 2015 - 2026 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Biomaker, 2015 - 2026 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.2.7. North America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.2.8. U.S.
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.2.9. Canada
      • 10.2.9.1. Overview
      • 10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Sample Type, 2015 - 2026 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Biomaker, 2015 - 2026 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.3.7. Europe Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.3.8. Germany
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.10. United Kingdom
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.11. France
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.3.12. Rest of Europe
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Sample Type, 2015 - 2026 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Biomaker, 2015 - 2026 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.4.7. Asia Pacific Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.9. China
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.11. South Korea
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.4.12. Rest of APAC
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Sample Type, 2015 - 2026 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Biomaker, 2015 - 2026 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.5.7. Latin America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.5.8. Brazil
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.9. Mexico
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.10. Argentina
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Sample Type, 2015 - 2026 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Biomaker, 2015 - 2026 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2015 - 2026 (US$ Million)
    • 10.6.7. Middle East and Africa Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
    • 10.6.8. Saudi Arabia
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 10.6.9. United Arab Emirates
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

11. KEY VENDOR ANALYSIS

  • 11.1. NeoGenomics Laboratories
    • 11.1.1. Company Snapshot
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Strategic Initiatives
  • 11.2. Guardant Health
  • 11.3. Biocept
  • 11.4. Cynvenio
  • 11.5. Qiagen
  • 11.6. RainDance Technologies
  • 11.7. Adaptive Biotechnologies
  • 11.8. Personal Genome Diagnostics
  • 11.9. Trovagene

12. 360 DEGREE ANALYSTVIEW

13. APPENDIX

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Liquid Biopsy market: Sample Type Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Sample Type
  • TABLE Global Liquid Biopsy market, by Sample Type 2015-2026 (USD Million)
  • TABLE Liquid Biopsy market: Biomaker Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Biomaker
  • TABLE Global Liquid Biopsy market, by Biomaker 2015-2026 (USD Million)
  • TABLE Liquid Biopsy market: Technology Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Liquid Biopsy market, by Technology 2015-2026 (USD Million)
  • TABLE Liquid Biopsy market: Application Snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Liquid Biopsy market, by Application 2015-2026 (USD Million)
  • TABLE Liquid Biopsy market: Regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Liquid Biopsy market, by Region 2015-2026 (USD Million)
  • TABLE North America Liquid Biopsy market, by Country, 2015-2026 (USD Million)
  • TABLE North America Liquid Biopsy market, by Sample Type, 2015-2026 (USD Million)
  • TABLE North America Liquid Biopsy market, by Technology, 2015-2026 (USD Million)
  • TABLE North America Liquid Biopsy market, by Biomaker, 2015-2026 (USD Million)
  • TABLE North America Liquid Biopsy market, by Application, 2015-2026 (USD Million)
  • TABLE Europe Liquid Biopsy market, by country, 2015-2026 (USD Million)
  • TABLE Europe Liquid Biopsy market, by Sample Type, 2015-2026 (USD Million)
  • TABLE Europe Liquid Biopsy market, by Technology, 2015-2026 (USD Million)
  • TABLE Europe Liquid Biopsy market, by Biomaker, 2015-2026 (USD Million)
  • TABLE Europe Liquid Biopsy market, by Application, 2015-2026 (USD Million)
  • TABLE Asia Pacific Liquid Biopsy market, by country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Liquid Biopsy market, by Sample Type, 2015-2026 (USD Million)
  • TABLE Asia Pacific Liquid Biopsy market, by Biomaker, 2015-2026 (USD Million)
  • TABLE Asia Pacific Liquid Biopsy market, by Technology, 2015-2026 (USD Million)
  • TABLE Asia Pacific Liquid Biopsy market, by Application, 2015-2026 (USD Million)
  • TABLE Latin America Liquid Biopsy market, by country, 2015-2026 (USD Million)
  • TABLE Latin America Liquid Biopsy market, by Sample Type, 2015-2026 (USD Million)
  • TABLE Latin America Liquid Biopsy market, by Biomaker, 2015-2026 (USD Million)
  • TABLE Latin America Liquid Biopsy market, by Technology, 2015-2026 (USD Million)
  • TABLE Latin America Liquid Biopsy market, by Application, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Liquid Biopsy market, by country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Liquid Biopsy market, by Sample Type, 2015-2026 (USD Million)

TABLE Middle East and Africa Liquid Biopsy market, by Biomaker, 2015-2026 (USD Million)

  • TABLE Middle East and Africa Liquid Biopsy market, by Technology, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Liquid Biopsy market, by Application, 2015-2026 (USD Million)

List of Figures

  • FIGURE Liquid Biopsy market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Sample Type segment market share analysis, 2019 & 2026
  • FIGURE Sample Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Urine Sample-based segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Blood Sample-based segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Technology segment market share analysis, 2019 & 2026
  • FIGURE Technology segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Multi-gene-parallel Analysis (NGS) segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Single Gene Analysis (PCR Microarrays) segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Biomaker segment market share analysis, 2019 & 2026
  • FIGURE Biomaker segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Circulating Tumor DNA (ctDNA) segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Circulating Tumor Cells (CTC) segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Exosomes segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Application segment market share analysis, 2019 & 2026
  • FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Molecular Health Monitoring segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Therapy Selection for Metastatic Breast Cancer (MBS) segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Therapy Selection for Other Metastatic Cancer segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Liquid Biopsy market share and leading players, 2018
  • FIGURE Europe Liquid Biopsy market share and leading players, 2018
  • FIGURE Asia Pacific Liquid Biopsy market share and leading players, 2018
  • FIGURE Latin America Liquid Biopsy market share and leading players, 2018
  • FIGURE Middle East and Africa Liquid Biopsy market share and leading players, 2018
  • FIGURE North America Liquid Biopsy market share analysis by country, 2018
  • FIGURE U.S. Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Liquid Biopsy market share analysis by country, 2018
  • FIGURE Germany Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE France Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Liquid Biopsy market share analysis by country, 2018
  • FIGURE India Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APAC Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Liquid Biopsy market share analysis by country, 2018
  • FIGURE Brazil Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Liquid Biopsy market share analysis by country, 2018
  • FIGURE Saudi Arabia Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Liquid Biopsy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
Back to Top